The effect of gD-derived peptides on T cell immune response mediated by BTLA-HVEM protein complex in melanoma patients
Article in Frontiers in Immunology (May 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Targeting BTLA with the peptide inhibitor HVEM(14-39) – A new way to restore the activity of T cells in melanoma
Article in Biomedicine & Pharmacotherapy (May 2024)
THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA
Article in Proceedings of the National Academy of Sciences of the United States of America (May 2024)